The Society for Immunotherapy of Cancer (SITC) Annual Meeting is the premier global event dedicated to cancer immunotherapy, attracting thousands of leading researchers, clinicians, and industry experts. The meeting covers the full spectrum of immuno-oncology, from basic science to clinical applications, making it a critical event for advancing immunotherapy research.
Palleos will be represented at SITC 2026 by Varvara Melnikova, Business Development Manager. If you are attending and would like to learn more about our oncology CRO expertise in immunotherapy, explore our clinical research services, or discuss how we can support your clinical trials services needs across Europe, Varvara would be happy to meet with you.
We also offer free feasibility assessments to help you evaluate the clinical and regulatory landscape for your immunotherapy studies in Europe. To arrange a meeting in Phoenix, please contact: info@palleos.com.